OLANDER CLINICAL CONSULTING 1 ApS: Financial statements 2024
CVR: 35532900
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
OLANDER CLINICAL CONSULTING 1 ApS (CVR 35532900) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,004 and a net result of DKK 30,979 compared with DKK 23,757 the year before. Equity in the 2024 report amounted to DKK 138,682. The solvency ratio was 92.2%.
- Revenue
- DKK 0
- Gross Profit
- DKK -1,004
- Profit/Loss
- DKK 30,979
- Equity
- DKK 138,682
- Total Assets
- DKK 150,362
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -1K | 31K | 139K | - |
| 2023 | 0 | -8K | 24K | 108K | - |
| 2022 | - | -7K | 30K | 114K | - |
| 2021 | - | -7K | 29K | 109K | - |
| 2020 | - | -6K | 23K | 104K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
OLANDER CLINICAL CONSULTING 1 ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 23,757.
About OLANDER CLINICAL CONSULTING 1 ApS
OLANDER CLINICAL CONSULTING 1 ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK 38,365 and a net result of DKK 28,455 compared with DKK 30,979 the year before. Equity in the 2025 report amounted to DKK 167,137.
